|Classification criteria for Sjögren’s syndrome|
C Vitali, N Del Papa
Sjögren's Syndrome, 47-60, 2016
|Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community|
C Vitali, S Bombardieri, HM Moutsopoulos, G Balestrieri, W Bencivelli, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1993
|Increased risk of lymphoma in sicca syndrome|
SS KASSAN, TL THOMAS, HM MOUTSOPOULOS, R HOOVER, ...
Annals of internal medicine 89 (6), 888-892, 1978
|Immune interferon in the circulation of patients with autoimmune disease|
JJ Hooks, HM Moutsopoulos, SA Geis, NI Stahl, JL Decker, AL Notkins
New England Journal of Medicine 301 (1), 5-8, 1979
|European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by …|
C Vitali, S Bombardieri, R Jonsson, HM Moutsopoulos, EL Alexander, ...
|Clinical manifestations and early diagnosis of Sjögren syndrome|
SS Kassan, HM Moutsopoulos
Archives of internal medicine 164 (12), 1275-1284, 2004
|The risk of lymphoma development in autoimmune diseases: a meta-analysis|
E Zintzaras, M Voulgarelis, HM Moutsopoulos
Archives of internal medicine 165 (20), 2337-2344, 2005
|Sjögren's syndrome (sicca syndrome): current issues|
HM MOUTSOPOULOS, TM CHUSED, DL MANN, JH KLIPPEL, AS FAUCI, ...
Annals of Internal Medicine 92 (2_Part_1), 212-226, 1980
|Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European …|
C Vitali, S Bombardieri, HM Moutsopoulos, J Coll, R Gerli, PY Hatron, ...
Annals of the rheumatic diseases 55 (2), 116-121, 1996
|Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome|
M Voulgarelis, UG Dafni, DA Isenberg, HM Moutsopoulos
Arthritis & Rheumatism: Official Journal of the American College of …, 1999
|Clinical evolution, and morbidity and mortalityof primary Sjögren's syndrome|
FN Skopouli, U Dafni, JPA Ioannidis, HM Moutsopoulos
Seminars in arthritis and rheumatism 29 (5), 296-304, 2000
|Long‐term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome|
JPA Ioannidis, VA Vassiliou, HM Moutsopoulos
Arthritis & Rheumatism 46 (3), 741-747, 2002
|Mortality in systemic sclerosis: an international meta-analysis of individual patient data|
JPA Ioannidis, PG Vlachoyiannopoulos, AB Haidich, TA Medsger Jr, ...
The American journal of medicine 118 (1), 2-10, 2005
|Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down‐regulation of the T cell costimulatory molecule CD40 ligand: an open‐label trial|
PP Sfikakis, JN Boletis, S Lionaki, V Vigklis, KG Fragiadaki, A Iniotaki, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2005
|Sjöc; gren's Syndrome: Autoimmune Epithelitis|
Clinical immunology and immunopathology 72 (2), 162-165, 1994
|Autoantibody profiles in the sera of European patients with myositis|
R Brouwer, GJD Hengstman, WV Egberts, H Ehrfeld, B Bozic, ...
Annals of the rheumatic diseases 60 (2), 116-123, 2001
|The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome.|
C Vitali, HM Moutsopoulos, S Bombardieri
Annals of the rheumatic diseases 53 (10), 637-647, 1994
|High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population.|
MN Manoussakis, AG Tzioufas, MP Silis, PJ Pange, J Goudevenos, ...
Clinical and experimental immunology 69 (3), 557, 1987
|Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study|
T Sokka, S Toloza, M Cutolo, H Kautiainen, H Makinen, F Gogus, V Skakic, ...
Arthritis research & therapy 11 (1), R7, 2009
|Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy|
GJD Hengstman, HJ Ter Laak, WTMV Egberts, IE Lundberg, ...
Annals of the rheumatic diseases 65 (12), 1635-1638, 2006